Walgreens has launched a private label version of Naloxone HCI Nasal Spray, which can reverse an overdose from opioids.
The new product retails for $34.99, a lower price than the comparable national brand product at Walgreens stores. The spray is currently available online and will be available chain-wide in all stores by the end of the month, where it can be found in the pain aisle.
The spray can be used in the event of an opioid overdose to temporarily reverse the effects of opioids – including heroin, illicit fentanyl, and prescription opioid medications—when administered in time.
Naloxone works by quickly blocking the effects of opioids on the brain, restoring normal breathing and preventing death due to overdose. Despite its proven efficacy, access to naloxone remains limited in many communities, exacerbating the toll of the opioid epidemic. Walgreens is offering naloxone at a lower price than the comparable national brand product at Walgreens stores to further enable access to this life-saving medication.
